Skip to main content

Composition and Stability of a Standard Marihuana Cigarette

  • Chapter
Marihuana and Medicine

Abstract

The recorded use of Cannabis dates back well over 3000 years, with use as an intoxicant and as a medicinal formulation contributing to its considerable historical presence. Despite the recognition and use of Cannabis as a medicinal natural product by many cultures, its use in Western medicine began to decrease early in this century. With the passing of the Marihuana Tax Act of 1937, its use was effectively prohibited and its cultivation was disallowed in the United States. In 1942, the U.S. Pharmacopeia removed marihuana from its listings. In the 1960s, however, whereas the medicinal and industrial use of marihuana continued to decrease in the United States, the use of marihuana as an illegal intoxicant increased dramatically. By the early 1990s, the only legal therapeutic application of Cannabis in the United States was to a small number of individuals (less than 20) who still received marihuana through a compassionate use program that was terminated in 1992. So it was remarkable when, despite numerous efforts to discourage marihuana use in the United States, grassroots organizations in Arizona and California were able to pass proposals to legalize the prescription and use of medicinal marihuana in 1997.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Turner, C. E., Hadley, K. W., Fetterman, P. S., Doorenbos, N. J., Quimby, M. W., and Waller, C. (1973) Constituents of Cannabis sativa L. IV: stability of cannabinoids in stored plant material. J. Pharm. Sci. 62, 1601–1605.

    Article  PubMed  CAS  Google Scholar 

  2. Farmilo and Lerner (1963)

    Google Scholar 

  3. Lerner and Zeffert (1968)

    Google Scholar 

  4. Davis, K. H., Jr., Martin, N. H., Pitt, C. G., Wildes, J. W., and Wall, M. E. (1970) The preparation and analysis of enriched and pure cannabinoids from marihuana and hashish. Lloydia 33, 453–460.

    PubMed  CAS  Google Scholar 

  5. Carlini, E. A., Santos, M., Claussen, U., Bieniek, D., and Korte, F. (1970) Structure-activity relation of four tetrahydocannabinols and the pharmacological activity of five semipurified extracts of Cannabis sativa. Psychopharmacology 18, 82–93.

    Article  CAS  Google Scholar 

  6. Karriol, I. G. and Carlini, E. A. (1973) Pharmacological interaction between cannabidiol and 49- tetrahydrocannabinol. Psychopharmacology.. 33: 53–70.

    Google Scholar 

  7. Karriol, I. G. and Carlini, E. A. (1973) Comparative study between semipurified extracts of marihuana obtained in Fermany and Brazil. Possible interference of cannabidiol and/or canabinol on the effect of D9trans-tetrahydrocannabinol. Cienc. Cult. 25, 749–751.

    Google Scholar 

  8. Fairbairn, J. W., Liebmann, J. A., and Rowan, M. G. (1976) The stability of Cannabis and its preparations on storage. J. Pharm. Pharmac. 28, 1–7.

    Article  CAS  Google Scholar 

  9. Harvey (1990)

    Google Scholar 

  10. Sherman et al. (1991)

    Google Scholar 

  11. Hollister (1986)

    Google Scholar 

  12. Chusid, M. J., Gelfand, J. A., Nutter, C., and Fauci, A. S. (1975) Pulmonary aspergillosis, inhalation of contaminated marihuana smoke, chrnic granulomatous disease. Ann. Int. Med. 82, 682–682.

    Article  PubMed  CAS  Google Scholar 

  13. Ungerleider, J. T., Andrysiak, T., Tashkin, D. P., and Gale, R. P. (1982) Contamination of marihuana cigarettes with pathogenic bacteria — possible source of infection in cancer patients. Cancer Treat. Lett. 66, 589–592.

    CAS  Google Scholar 

  14. Kagen, S. L., Kurup, V. P., Sohnle, P. G., and Fink, J. N. (1983) Marihuana smoking and fungal sensitizatioin. J. Allergy Clin. Immunol. 71, 389–393.

    Article  PubMed  CAS  Google Scholar 

  15. Karup, V. P., Resnick, A., Kagen, S. L., Cohen, S. H., and Fink, J. N. (1983) Allergenic fungi and actinomycetes in smoking materials and their health implications. Mycopathologia 82, 61–64.

    Article  Google Scholar 

  16. Perez-Reyes, M. (1990) Marihuana smoking: factors that influence the bioavailability of tetrahydrocannabinol, In: ( Chiang, N.C. and Hawks R., eds.), Research Findings on Smoking of Abused Substances, NIDA Research Monograph vol. 99, pp. 42–61.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Thomas, B.F. et al. (1999). Composition and Stability of a Standard Marihuana Cigarette. In: Nahas, G.G., Sutin, K.M., Harvey, D., Agurell, S., Pace, N., Cancro, R. (eds) Marihuana and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-710-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-710-9_14

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-5717-0

  • Online ISBN: 978-1-59259-710-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics